Avidity Biosciences Inc (RNAM) Financials

Stock symbol RNAM is outdated, potentially delisted? Maybe it is available on other exchange?

RNAM Assets vs Liabilities

Date	Assets	Liabilities
Dec. 31, 2025	2.0 billion	269.5 million
Sept. 30, 2025	2.1 billion	247.9 million
June 30, 2025	1.4 billion	176.3 million
March 31, 2025	1.5 billion	130.4 million

RNAM Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Dec. 31, 2025	-175.3 million	43.4 million
Sept. 30, 2025	-156.9 million	19.0 million
June 30, 2025	-203.0 million	17.7 million
March 31, 2025	-128.6 million	17.7 million

RNAM Net Income

No data available :(

RNAM Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Dec. 31, 2025	1.7 billion	90.6 million	45.3 million
Sept. 30, 2025	1.9 billion	92.0 million	46.0 million
June 30, 2025	1.2 billion	2.4 million	1.2 million
March 31, 2025	1.4 billion	4.2 million	2.1 million

RNAM Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Dec. 31, 2025	149.3 million
Sept. 30, 2025	137.9 million
June 30, 2025	129.6 million
March 31, 2025	129.2 million

RNAM Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Dec. 31, 2025	5.5 million	166.6 million	87.2 million	-
Sept. 30, 2025	712000	154.9 million	45.3 million	-
June 30, 2025	3.3 million	138.1 million	36.1 million	-
March 31, 2025	3.8 million	99.5 million	32.8 million	-

RNAM Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Dec. 31, 2025	860000	1.5 million
Sept. 30, 2025	12.5 million	1.1 million
June 30, 2025	3.8 million	814000
March 31, 2025	1.6 million	785000

RNAM

Price: $72.82

52 week price:

21.51

73.06

Earnings Per Share: -4.19 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 11.2 billion

Links:

RNAM on Yahoo Finance